Canada’s Top 100 Corporate R&D Spenders 2018
Top Corporate R&D Spenders by Tier - Winners Circle





R&D Spending FY2017
R&D
Spending
Overall Tier 1 $000
1       1       Bombardier Inc. $1,603,771
2       2       Magna International Inc. $677,869
3       3       IBM Canada Ltd. (fs) $525,000
R&D
Spending
Overall Tier 2 $000
1       32       Pfizer Canada Inc. (fs) $97,865
2       33       Linamar Corporation $86,605
3       34       Arbutus Biopharma Corporation $81,391
R&D
Spending
Overall Tier 3 $000
1       71       IMAX Corporation $27,082
2       72       L3 WESCAM (fs) $26,462
3       73       Pason Systems Inc. $25,219
R&D Spending Growth
(% Change FY2016-FY2017)
R&D
Spending
Growth
Overall Tier 1 %
1       20       Shopify Inc. 79.3   
2       11       Suncor Energy Inc. 75.0   
3       9       Open Text Corporation 42.3   
R&D
Spending
Growth
Overall Tier 2 %
1       41       Novelion Therapeutics Inc. 224.9   
2       52       Lockheed Martin Canada (fs) 176.8   
3       54       Aurinia Pharmaceuticals Inc. 128.8   
R&D
Spending
Growth
Overall Tier 3 %
1       79       Field Upgrading Limited 99.6   
2       92       Theratechnologies Inc. 56.1   
3       88       BSM Technologies Inc. 47.5   
R&D Intensity* FY2017
(R&D Spending as % of Revenue)
R&D
Intensity
Overall Tier 1 %
1       30       ProMetic Life Sciences Inc. 260.6   
2       13       BlackBerry Limited 25.6   
3       20       Shopify Inc. 20.2   
R&D
Intensity
Overall Tier 2 %
1       34       Arbutus Biopharma Corporation 585.8   
2       48       Zymeworks Inc. 80.7   
3       41       Novelion Therapeutics Inc. 35.4   
R&D
Intensity
Overall Tier 3 %
1       91       Intellipharmaceutics International Inc. 168.4   
2       80       Espial Group Inc. 57.7   
3       92       Theratechnologies Inc. 27.7   


Notes:
  1. Data were obtained through annual reports, financial statements, securities commission filings, or through a survey.
  2. We have attempted, wherever possible, to provide gross R&D Spending before deduction of investment tax credits or government grants.
  3. We have attempted, wherever possible, to provide revenue net of interest and investment income.
  4. Canadian-owned company results include worldwide revenue and R&D Spending; foreign subsidiaries fs for their Canadian operations only.
  5. R&D Spending Tiers: Tier 1 = $100 million or more of R&D Spending, Tier 2 = $30 million-$99.9 million, Tier 3 = less than $30 million.
*Based on companies with $2 million or more of revenue
fs = Foreign subsidiary (includes revenue and R&D Spending for Canadian operations only)


Top
Top